BOSTON, June 06, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced that it has filed its definitive proxy statement with the Securities and ...
Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Radius Class A common stock is listed on the Nasdaq ...
MONSEY, N.Y., April 24, 2023 (GLOBE NEWSWIRE) -- After the filing of a preliminary proxy, the law firm of Wohl & Fruchter LLP continues to investigate the fairness of the price of $15.00 per share in ...